Dose-related difference in progression rates of cytomegalovirus retinopathy during foscarnet maintenance therapy

American Journal of Ophthalmology

Volumn 119, Issue 5, 1995, Pages 576-586

  Holland, G N ^a   Levinson, R D ^a   Jacobson, M A ^a   Causey, D ^a   Davis, R ^a   Feinberg, J E ^a   Hardy, W D ^a   Heinemann, M H ^a   Kuppermann, B D ^a   Mills, J ^a   O'Donnell, J J ^a   Polsky, B ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINOPATHY;

EID: 0029003664     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)70215-6     Document Type: Article

References (9)

1. MA Jacobson JJ O'Donnell J Mills Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome Antimicrob Agents Chemother 33 1989 736 741
2. AG Palestine MA Polis MD De Smet BF Baird J Falloon JA Kovacs A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS Ann Intern Med 115 1991 665 673
3. MA Jacobson D Causey B Polsky D Hardy M Chown R Davis A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS J Infect Dis 168 1993 444 448
4. GN Holland JD Shuler Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients Arch Ophthalmol 110 1992 1435 1442
5. AIDS Clinical Trials Group (ACTG) Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial, 1: rationale, design, and methods Control Clin Trials 13 1992 22 39
6. F Aweeka J Gambertoglio J Mills MA Jacobson Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis Antimicrob Agents Chemother 33 1989 742 745
7. GN Holland WC Buhles Jr B Mastre HJ Kaplan UCLA CMV Retinopathy Study Group. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome Arch Ophthalmol 107 1989 1759 1766
8. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial, 4: visual outcomes Ophthalmology 101 1994 1250 1261
9. Studies of Ocular Complications of AIDS (SOCA) Research Group, in collaboration with the AIDS Clinical Trials Group (ACTG) Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis N Engl J Med 326 1992 213 220